Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: Possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer

Kimberly R. Kalli, Sarah V. Bradley, Susanne Fuchshuber, Cheryl A. Conover

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: Possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences